Literature DB >> 24070323

Saposin C protects glucocerebrosidase against α-synuclein inhibition.

Thai Leong Yap1, James M Gruschus, Arash Velayati, Ellen Sidransky, Jennifer C Lee.   

Abstract

Mutations in GBA1, the gene for glucocerebrosidase (GCase), are genetic risk factors for Parkinson disease (PD). α-Synuclein (α-Syn), a protein implicated in PD, interacts with GCase and efficiently inhibits enzyme activity. GCase deficiency causes the lysosomal storage disorder Gaucher disease (GD). We show that saposin C (Sap C), a protein vital for GCase activity in vivo, protects GCase against α-syn inhibition. Using nuclear magnetic resonance spectroscopy, site-specific fluorescence, and Förster energy transfer probes, Sap C was observed to displace α-syn from GCase in solution and on lipid vesicles. Our results suggest that Sap C might play a crucial role in GD-related PD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24070323      PMCID: PMC3833811          DOI: 10.1021/bi401191v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.

Authors:  A M Vaccaro; M Tatti; F Ciaffoni; R Salvioli; A Barca; C Scerch
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

2.  Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C.

Authors:  Jean-René Alattia; James E Shaw; Christopher M Yip; Gilbert G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

3.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

4.  An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.

Authors:  Sílvia Atrian; Eduardo López-Viñas; Paulino Gómez-Puertas; Amparo Chabás; Lluïsa Vilageliu; Daniel Grinberg
Journal:  Proteins       Date:  2008-02-15

Review 5.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

6.  Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.

Authors:  S Weiler; Y Kishimoto; J S O'Brien; J A Barranger; J M Tomich
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

7.  Function of saposin C in the reconstitution of glucosylceramidase by phosphatidylserine liposomes.

Authors:  A M Vaccaro; M Tatti; F Ciaffoni; R Salvioli; B Maras; A Barca
Journal:  FEBS Lett       Date:  1993-12-20       Impact factor: 4.124

8.  Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.

Authors:  Amy B Manning-Boğ; Birgitt Schüle; J William Langston
Journal:  Neurotoxicology       Date:  2009-07-02       Impact factor: 4.294

9.  Non-neuronopathic Gaucher disease due to saposin C deficiency.

Authors:  A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz
Journal:  Clin Genet       Date:  2007-10-07       Impact factor: 4.438

10.  Crystal structures of human saposins C andD: implications for lipid recognition and membrane interactions.

Authors:  Maxim Rossmann; Robert Schultz-Heienbrok; Joachim Behlke; Natascha Remmel; Claudia Alings; Konrad Sandhoff; Wolfram Saenger; Timm Maier
Journal:  Structure       Date:  2008-05       Impact factor: 5.006

View more
  14 in total

1.  Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy.

Authors:  Thai Leong Yap; Zhiping Jiang; Frank Heinrich; James M Gruschus; Candace M Pfefferkorn; Marilia Barros; Joseph E Curtis; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2014-11-26       Impact factor: 5.157

Review 2.  The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.

Authors:  Elma Aflaki; Wendy Westbroek; Ellen Sidransky
Journal:  Neuron       Date:  2017-02-22       Impact factor: 17.173

3.  Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C.

Authors:  James M Gruschus; Zhiping Jiang; Thai Leong Yap; Stephanie A Hill; Alexander Grishaev; Grzegorz Piszczek; Ellen Sidransky; Jennifer C Lee
Journal:  Biochem Biophys Res Commun       Date:  2015-01-17       Impact factor: 3.575

4.  Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes.

Authors:  Rika Kojima; Mark Zurbruegg; Tianyi Li; Wojciech Paslawski; Xiaoqun Zhang; Per Svenningsson
Journal:  J Mol Neurosci       Date:  2022-09-24       Impact factor: 2.866

5.  Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease.

Authors:  Yong-Ping Chen; Xiao-Jing Gu; Ru-Wei Ou; Ling-Yu Zhang; Yan-Bing Hou; Kun-Cheng Liu; Bei Cao; Qian-Qian Wei; Wei Song; Bi Zhao; Ying Wu; Jing-Qiu Cheng; Hui-Fang Shang
Journal:  Mol Neurobiol       Date:  2020-11-20       Impact factor: 5.590

Review 6.  Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.

Authors:  Emily C Daykin; Emory Ryan; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2021-01-09       Impact factor: 4.797

Review 7.  A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.

Authors:  Jérôme Stirnemann; Nadia Belmatoug; Fabrice Camou; Christine Serratrice; Roseline Froissart; Catherine Caillaud; Thierry Levade; Leonardo Astudillo; Jacques Serratrice; Anaïs Brassier; Christian Rose; Thierry Billette de Villemeur; Marc G Berger
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

8.  Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.

Authors:  Ying Sun; Benjamin Liou; Zhengtao Chu; Venette Fannin; Rachel Blackwood; Yanyan Peng; Gregory A Grabowski; Harold W Davis; Xiaoyang Qi
Journal:  EBioMedicine       Date:  2020-04-10       Impact factor: 8.143

Review 9.  Neurological effects of glucocerebrosidase gene mutations.

Authors:  S Mullin; D Hughes; A Mehta; A H V Schapira
Journal:  Eur J Neurol       Date:  2018-12-13       Impact factor: 6.089

10.  Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.

Authors:  James M Gruschus
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.